Corcept Therapeutics Statistics
NASDAQ: CORTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
63.62-1.36 (-2.09%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Corcept Therapeutics by the numbers
Corcept Therapeutics has a market capitalization of $6.96 billion based on 109.44M shares outstanding. Its trailing P/E ratio is 47.8, and its forward P/E is 12.8. The stock trades 35.8% below its 50-day average and 17.6% below its 200-day average.
Average daily trading volume is 1.26M shares, or about $80.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CORT valuation vs. peer median
| Metric | CORT | Peer median | Difference |
|---|---|---|---|
| Market cap | $6.96B | $7.22B | -4% |
| Forward P/E | 12.8 | 35.5 | -64% |
| Avg. volume | 1.26M | 1.22M | +4% |
Peer median across 8 companies: CYTK, AXSM, AMRX, KNSA, ABVX, ALKS, MIRM, RYTM.
Valuation
- Market cap
- $6.96B
- P/E (TTM)
- 47.83
- Forward P/E
- 12.77
- Price / sales (latest FY)
- 9.14
- EPS (TTM)
- $1.33
- Shares outstanding
- 109.44M
Price and trading
- Previous close
- 64.98
- Open
- 64.07
- Day range
- 62.81 – 65.13
- 52-week range
- 28.66 – 126.38
- 52-week change
- -17.69%
- Beta
- —
- Volume
- 1.09M
- Average volume
- 1.26M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 6.96B
- Pe
- 47.83
- Forward Pe
- 12.77
- Eps
- 1.33
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 126.38
- Week52 Low
- 28.66
- Avg Volume
- 1.26M
- Shares Outstanding
- 109.44M
- Ma50
- 99.03
- Ma200
- 77.18
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -49.66%
- Pct From52w Low
- 121.98%